
Noa Simchoni, MD, PhD
Pulmonary Critical Care • Sleep MedicineInterstitial Lung Disease (ILD) Mission Bay



Noa Simchoni, MD, PhD
Pulmonary Critical Care • Sleep MedicineInterstitial Lung Disease (ILD) Mission Bay
On this page
About me
Education & training
Board certification
- Critical Care Medicine, American Board of Internal Medicine
- Pulmonary Disease, American Board of Internal Med/Pulmonary Disease
- Internal Medicine, American Board of Internal Medicine
Fellowship
- Pulmonary, Critical Care, and Sleep Medicine, UCSF Graduate Medical Education
Residency
- Internal Medicine, University of CA at San Francisco School of Med
Internship
- Internal Medicine, University of CA at San Francisco School of Med
Degree
- MD, ICAHN School of Medicine at Mount Sinai
My expertise
Specialties
- Pulmonary Critical Care
- Sleep Medicine
- Interstitial Lung Disease
Locations
Component Name: Provider Research Listing component built but no clinical trials or publications to display
Clinical Trials query: q=health_gateway_id_ss%3A%28%222883%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%222883%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.